Search research articles
Contact Us
Filters
Showing results (361-370 of 455) with videos related to
Page
of 46
Sort By:
Research in Medical Education : Proceedings of the ... Annual Conference. Conference on Research in Medical Education
|
January 1, 1984
Visual arts training to enhance observational skills of medical students
M H Appel, C Stegeman, R Mark, et al.
Brain, Behavior, and Immunity
|
December 24, 2010
Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice
David R Beers, Weihua Zhao, Bing Liao, et al.
Brain : a Journal of Neurology
|
May 21, 2011
Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
David R Beers, Jenny S Henkel, Weihua Zhao, et al.
Neuroscience
|
September 1, 1995
Alpha-1 subunits of voltage gated Ca2+ channels in the mesencephalon x neuroblastoma hybrid cell line MES23.5
T Schneider, E Perez-Reyes, O Nyormoi, et al.
Brain, Behavior, & Immunity - Health
|
September 30, 2021
Serum programmed cell death proteins in amyotrophic lateral sclerosis
David R Beers, Weihua Zhao, Jason R Thonhoff, et al.
Biochemical and Biophysical Research Communications
|
March 7, 2006
Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease
Ira L Goldknopf, Essam A Sheta, Jennifer Bryson, et al.
Annals of Neurology
|
February 1, 1994
Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit
F Kimura, R G Smith, O Delbono, et al.
Neurobiology of Disease
|
October 21, 1999
T cell receptor BV gene rearrangements in the spinal cords and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
M A Panzara, E Gussoni, A B Begovich, et al.
Annals of Clinical and Translational Neurology
|
April 7, 2026
Longitudinal Assessment of Biomarkers in ALS: Discriminative Biomarkers for Disease Progression and Survival
David R Beers, Yueh-Yun Lin, Jason R Thonhoff, et al.
Frontiers in Neurology
|
June 25, 2024
A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses with combination therapy of CTLA4-Ig and interleukin-2 in amyotrophic lateral sclerosis
Jason R Thonhoff, David R Beers, Weihua Zhao, et al.
Page
of 46
Search research articles
Search
Showing results (361-370 of 455) with videos related to
Sort By:
Page
of 46
Research in Medical Education : Proceedings of the ... Annual Conference. Conference on Research in Medical Education
|
January 1, 1984
Visual arts training to enhance observational skills of medical students
M H Appel, C Stegeman, R Mark, et al.
Brain, Behavior, and Immunity
|
December 24, 2010
Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice
David R Beers, Weihua Zhao, Bing Liao, et al.
Brain : a Journal of Neurology
|
May 21, 2011
Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis
David R Beers, Jenny S Henkel, Weihua Zhao, et al.
Neuroscience
|
September 1, 1995
Alpha-1 subunits of voltage gated Ca2+ channels in the mesencephalon x neuroblastoma hybrid cell line MES23.5
T Schneider, E Perez-Reyes, O Nyormoi, et al.
Brain, Behavior, & Immunity - Health
|
September 30, 2021
Serum programmed cell death proteins in amyotrophic lateral sclerosis
David R Beers, Weihua Zhao, Jason R Thonhoff, et al.
Biochemical and Biophysical Research Communications
|
March 7, 2006
Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease
Ira L Goldknopf, Essam A Sheta, Jennifer Bryson, et al.
Annals of Neurology
|
February 1, 1994
Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit
F Kimura, R G Smith, O Delbono, et al.
Neurobiology of Disease
|
October 21, 1999
T cell receptor BV gene rearrangements in the spinal cords and cerebrospinal fluid of patients with amyotrophic lateral sclerosis
M A Panzara, E Gussoni, A B Begovich, et al.
Annals of Clinical and Translational Neurology
|
April 7, 2026
Longitudinal Assessment of Biomarkers in ALS: Discriminative Biomarkers for Disease Progression and Survival
David R Beers, Yueh-Yun Lin, Jason R Thonhoff, et al.
Frontiers in Neurology
|
June 25, 2024
A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses with combination therapy of CTLA4-Ig and interleukin-2 in amyotrophic lateral sclerosis
Jason R Thonhoff, David R Beers, Weihua Zhao, et al.
Page
of 46